跳转至内容
Merck
CN

1342321

USP

Insulin lispro

United States Pharmacopeia (USP) Reference Standard

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C257H383N65O77S6
化学文摘社编号:
分子量:
5807.57
MDL number:
UNSPSC Code:
41116107
NACRES:
NA.24
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

InChI key

WNRQPCUGRUFHED-DETKDSODSA-N

grade

pharmaceutical primary standard

API family

insulin

form

crystalline powder

manufacturer/tradename

USP

application(s)

USP Biologics
pharmaceutical (small molecule)

format

neat

storage temp.

−20°C

正在寻找类似产品? 访问 产品对比指南

General description

Insulin Lispro is a fast-acting insulin analog created through recombinant DNA methods. It features a reversed sequence of lysine and proline at positions B28 and B29, resulting in rapid onset of action. This insulin analog is employed to manage blood glucose levels around meal times.

The USP biologics proteins category provides critical standards and reference materials necessary for the development and manufacturing of therapeutic proteins. These proteins, which can be naturally derived or genetically engineered, are essential in treating various diseases and conditions, ensuring that they meet quality, safety, and efficacy standards.

The United States Pharmacopeia (USP) provides quality standards for biologics to ensure their safety, efficacy, and quality throughout the manufacturing process. These standards assist manufacturers in adhering to regulatory requirements and help safeguard public health by reducing risks associated with biologics.

Application

Insulin lispro USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:
  • Insulin Lispro Injection

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Other Notes

Sales restrictions may apply.
This product is part of the USP Biologics program.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

存储类别

11 - Combustible Solids

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

监管及禁止进口产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Insulin Lispro
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 44(4), 2353-2353 (2019)
Insulin Assays
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 43(4) (2020)
Insulin Lispro Injection
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 44(4), 2355-2355 (2019)

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持